Histopathological analysis of angiogenic factors in renal cell carcinoma

International Journal of Urology

Volumn 10, Issue 4, 2003, Pages 220-227

  Yagasaki, Hiroki ^a   Kawata, Nozomu ^a   Takimoto, Yukie ^a   Nemoto, Norimichi ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

MMP 2; MVD; Renal cell carcinoma; TGF 1; VEGF

Indexed keywords

ANGIOGENIC FACTOR; ENDOGLIN; FORMALDEHYDE; GELATINASE A; MONOCLONAL ANTIBODY; PARAFFIN; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CORRELATION ANALYSIS; DENSITY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MICROVASCULATURE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEPHRECTOMY; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE; TISSUE SECTION; TUMOR VOLUME;

CARCINOMA, RENAL CELL; CONFIDENCE INTERVALS; ENDOTHELIAL GROWTH FACTORS; HUMANS; IMMUNOENZYME TECHNIQUES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY NEOPLASMS; LOGISTIC MODELS; LYMPHOKINES; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; SURVIVAL ANALYSIS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0038823647     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0919-8172.2003.00608.x     Document Type: Article

References (30)

1. Maruko K, Satomi Y, Miyano N et al. The prevalence of renal cell carcinoma: a nation wide survey in Japan in 1997. Int. J. Urol. 2001; 8: 359-65.
2. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N. Engl. J. Med. 1991; 324: 1-8.
3. Wakui S, Furusato M, Itoh T et al. Tumor angiogenesis in prostatic carcinoma with and without born metastasis; a morphometric study. J. Pathol. 1992; 168: 257-62.
4. Cheryl A, Jennifer J, Miao J, Jill M, Jordan L, Mary E. Endoglin expression as a measure of microvessel density in cervical cancer. Obstet. Gynecol. 2000; 96: 224-8.
5. Liotta LA, Steeg PS, Stetler WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991; 64: 327-36.
6. Paradis V, Lagha BN, Zeimoura L et al. Expression of vascular endothelial growth factor in renal cell carcinoma. Virchows Arch. 2000; 436: 351-6.
7. Slaton WJ, Inoue K, Perrotte P et al. Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma. Am. J. Pathol. 2001; 158: 735-43.
8. Ramp U, Jaquet K, Reinecke P, Nitsch T, Gabbert EH, Gerharz DC. Acquisition of TGF-β1 resistance: An important progression factor in human renal cell carcinoma. Laboratory Invest. 1997; 76: 739-49.
9. Kugler A, Hemmerlein B, Thelen P, Kallerhoff M, Radzun JH, Ringert HR. Expression of metalloproteinase 2 and 9 and their inhibitors in renal cell carcinoma. J. Urol. 1998; 160: 1914-8.
10. Stökel S, Ebel JN, Adlakha K et al. Classification renal cell carcinoma. Cancer 1997; 80: 987-9.
11. Medelros LJ, Jones EC, Alzawa S et al. Grading renal cell carcinoma. Cancer 1997; 80: 990-1.
12. Guinan P, Sobin LH, Algaba F et al. TMN staging of renal cell carcinoma. Cancer 1997; 80: 992-3.
13. Filder IJ. Critical factors in the biology of human cancer metastasis: Twenty-eighth G.H.A. Clowes Memorial Award Lecture. Cancer Res. 1990; 50: 6130.
14. Takahashi A, Sasaki H, Kim SJ et al. Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis. Cancer Res. 1994; 54: 4233-41.
15. Brown LF, Berse B, Jackman RW et al. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am. J. Pathol. 1993; 143: 1255-9.
16. Nicol D, Hii S, Walsh M et al. Vascular endothelial growth factor expression is increased in renal cell carcinoma. J. Urol. 1997; 157: 1482-6.
17. Cardillo RM, Lazzereschi D, Gandini O, Silverio DF, Colletta G. Transforming growth factor-β1 pathway in human renal cell carcinoma and surrounding normal-appearing renal parenchyma. Anal. Quant. Cytol. Histol. 2001; 23: 109-17.
18. Massague J. TGF-β signal transduction. Annu. Rev. Biochem. 1998; 67: 753-91.
19. Kallakury VB, Karikehalli S, Haholu A, Sheehan EC, Azumi N, Ross SJ. Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma. Clin. Cancer Res. 2001; 7: 3113-9.
20. Hagemann T, Gunawan B, Schulz M, Fuzesi L, Binder C. mRNA expression of matrix metalloproteinases and their inhibitors differs in subtypes of renal cell carcinoma. Eur. J. Cancer 2001; 37: 1839-46.
21. Montesano R, Orci L. Tumor-promoting phorbal esters induce angiogenesis in vitro. Cell 1985; 42: 469-77.
22. Lein M, Jung K, Laube C et al. Matrix-metalloproteinases and their inhibitors in plasma and tumor tissue in patient with renal cell carcinoma. Int. J. Cancer 2000; 85: 801-4.
23. Bochner RA, Cote RJ, Weidner N et al. Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. J. Natl. Cancer Inst. 1994; 87: 1603-5.
24. Kumar S, Ghellal A, Li C et al. Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis. Cancer Res. 1999; 59: 856-61.
25. Kumar P, Wang MJ, Bernabeu C. CD105 and angiogenesis. J. Pathol. 1996; 178: 363-6.
26. Kawata N, Yagasaki H, Fujimura K et al. Histopathological analysis of angiogenic factors in localized renal cell carcinoma: The influence of neoadjuvant treatment. Int. J. Urol. 2001; 8: 275-81.
27. Delahunt B, Bethwaite BP, Thornton A. Prognostic significance of microscopic vascularity for clear cell renal cell carcinoma. Br. J. Urol. 1997; 80: 401-4.
28. Hemmerlein B, Kugler A, Ozisik R, Ringert HR, Radzum JH, Thelen P. Vascular endothelial growth factor expression, angiogenesis and necrosis in renal cell carcinoma. Virchows Arch. 2001; 439: 645-52.
29. Davidson B, Goldberg I, Gotlieb WH et al. The prognostic value of metalloproteinases and angiogenic factors in ovarian carcinoma. Mol. Cell Endocrinol. 2002; 187: 39-45.
30. Kurizaki T, Toi M, Tominaga T. Relationship between matrix metalloproteinase and tumor angiogenesis in human breast carcinoma. Oncol. Report 1998; 5: 673-7.